Presentation is loading. Please wait.

Presentation is loading. Please wait.

ADC imaging. ADC imaging. A, Delineation of the ROI (left, green limits), intensity versus b value graph of a representative pixel (right), and a parametric.

Published byΑντιγόνη Αναγνωστάκης Modified over 5 years ago

Similar presentations

Presentation on theme: "ADC imaging. ADC imaging. A, Delineation of the ROI (left, green limits), intensity versus b value graph of a representative pixel (right), and a parametric."— Presentation transcript:

1 ADC imaging. ADC imaging. A, Delineation of the ROI (left, green limits), intensity versus b value graph of a representative pixel (right), and a parametric color-coded map (center). Serial histograms over time on the second week (B) and on the third week (C) after tumor implantation depict a progressive leftward shift reflecting a decrease in ADC values secondary to increased tumor growth and cellularity. A.R. Borges et al. AJNR Am J Neuroradiol 2012;33:24-36 ©2012 by American Society of Neuroradiology

Download ppt "ADC imaging. ADC imaging. A, Delineation of the ROI (left, green limits), intensity versus b value graph of a representative pixel (right), and a parametric."

Similar presentations

Color pressure maps (mm Hg) in a healthy subject in the axial (A) and coronal (D) planes as well as for a patient (C and F) with a type IIa DAVF affecting.

Color pressure maps (mm Hg) in a healthy subject in the axial (A) and coronal (D) planes as well as for a patient (C and F) with a type IIa DAVF affecting.
Bar graph showing the number of patients with respect to temporary diagnostic relief according to the 5-point patient outcome scale when interviewed 2.

Bar graph showing the number of patients with respect to temporary diagnostic relief according to the 5-point patient outcome scale when interviewed 2.
A and B, Sagittal (A) and axial (B) fast spin-echo images of the cervical spine before treatment demonstrate diffuse increase in signal intensity (arrows)

A and B, Sagittal (A) and axial (B) fast spin-echo images of the cervical spine before treatment demonstrate diffuse increase in signal intensity (arrows)
A 76-year-old man with a carcinoma ex pleomorphic adenoma (case 2).

A 76-year-old man with a carcinoma ex pleomorphic adenoma (case 2).
Axial fat-suppressed T2-weighted images (left panels), color ADC maps (middle panels), and photomicrographs (right panels) of lymphomas and carcinomas.

Axial fat-suppressed T2-weighted images (left panels), color ADC maps (middle panels), and photomicrographs (right panels) of lymphomas and carcinomas.
A 25-year-old man evaluated for long-term migraine problems.

A 25-year-old man evaluated for long-term migraine problems.
Line graph showing change in size over time relative to baseline CT

Line graph showing change in size over time relative to baseline CT
Photograph, CT, and MR imaging of the patient.

Photograph, CT, and MR imaging of the patient.
Visualization of computational image feature descriptors.

Visualization of computational image feature descriptors.
Receiver operating characteristic curves with statistical significance are shown. Receiver operating characteristic curves with statistical significance.

Receiver operating characteristic curves with statistical significance are shown. Receiver operating characteristic curves with statistical significance.
Serial axial T2-weighted images (2000/110/2 at treatment, 3400/100/4 at 6 months and 4000/100/3 at 10 months and 36 months after treatment) in a 52-year-old.

Serial axial T2-weighted images (2000/110/2 at treatment, 3400/100/4 at 6 months and 4000/100/3 at 10 months and 36 months after treatment) in a 52-year-old.
Diffusion-weighted (TR = 3900, TE = 94, B = 1000, number of gradient directions = 90) imaging (A) with corresponding apparent diffusion coefficient map.

Diffusion-weighted (TR = 3900, TE = 94, B = 1000, number of gradient directions = 90) imaging (A) with corresponding apparent diffusion coefficient map.
A side-by-side comparison of EPVS in a cognitively healthy control versus a patient with aMCI A, A coronal MR brain image of a cognitively healthy control.

A side-by-side comparison of EPVS in a cognitively healthy control versus a patient with aMCI A, A coronal MR brain image of a cognitively healthy control.
FLAIR scan, FA map, and fiber tracking in a 38-year-old patient with TBI who was imaged 2 weeks after the initial trauma. FLAIR scan, FA map, and fiber.

FLAIR scan, FA map, and fiber tracking in a 38-year-old patient with TBI who was imaged 2 weeks after the initial trauma. FLAIR scan, FA map, and fiber.
MEG SAMg2 data superimposed on coronal reformation (A), sagittal reformation (B), and axial MPRAGE MR imaging (C). MEG SAMg2 data superimposed on coronal.

MEG SAMg2 data superimposed on coronal reformation (A), sagittal reformation (B), and axial MPRAGE MR imaging (C). MEG SAMg2 data superimposed on coronal.
Images obtained in a 67-year-old woman with posttreatment glioblastoma who had ETP. Contrast-enhanced, T1-weighted imaging (A) performed 4 weeks after.

Images obtained in a 67-year-old woman with posttreatment glioblastoma who had ETP. Contrast-enhanced, T1-weighted imaging (A) performed 4 weeks after.
Source dynamic MR image (A), signal intensity time curves (S) (B), and color-coded perfusion map (overlaid on the corresponding FLAIR image) (C) of a male.

Source dynamic MR image (A), signal intensity time curves (S) (B), and color-coded perfusion map (overlaid on the corresponding FLAIR image) (C) of a male.
Graphs comparing average absolute change in thyroid gland size (A) and average percentage change in thyroid gland size (B) after XRT by quarter-year increments.

Graphs comparing average absolute change in thyroid gland size (A) and average percentage change in thyroid gland size (B) after XRT by quarter-year increments.
Pseudoresponse. Pseudoresponse. A 47-year-old man with GBM. A reduction of the enhancing portion of the lesion is observed 1 day after initiation of cediranib.

Pseudoresponse. Pseudoresponse. A 47-year-old man with GBM. A reduction of the enhancing portion of the lesion is observed 1 day after initiation of cediranib.
A 59-year-old womam with HPV− HNSCC (T2N0M0).

A 59-year-old womam with HPV− HNSCC (T2N0M0).

Similar presentations

Ads by Google